NYSE:DVAHealthcare
A Look At DaVita (DVA) Valuation As Analyst Upgrades And AI Efforts Support Earnings Outlook
Event driven focus on DaVita
DaVita (DVA) is back on investor watchlists after fresh analyst estimate revisions pointed to higher earnings expectations, along with new AI driven efforts aimed at improving patient care and operational efficiency.
See our latest analysis for DaVita.
At a share price of US$145.58, DaVita has given investors a 26.9% 90 day share price return and a 76.03% three year total shareholder return. This suggests that recent momentum has built on a longer recovery trend...